• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Robert W. Dubois Explains the Growing Importance of Clinical Pathways

Video

Pathways, particularly in oncology, have been gaining a lot more attention lately as payers are looking to bundle payments, Robert W. Dubois, MD, PhD, chief science officer and executive vice president of the National Pharmaceutical Council, explained at the Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo in San Diego, April 7-10.

Pathways, particularly in oncology, have been gaining a lot more attention lately as payers are looking to bundle payments, Robert W. Dubois, MD, PhD, chief science officer and executive vice president of the National Pharmaceutical Council, explained at the Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo in San Diego, April 7-10.

Companies like Anthem, United, and Aetna are looking to pay specialists for blocks of services instead of individual payments for individual services, he explained.

"So as the healthcare financial situation changes from fee for service to a pay for a block of services or pay for performance, we're going to see more and more exploration of pathways," Dr Dubois said.

Related Videos
Screenshot of an interview with Nicolas Girard, MD, PhD
Byoung Chul Cho, MD, PhD
Beth Stein, MD, and Ratna Kiran Bhavaraju-Sanka, MD
Efren Flores, MD
Ravi Vij, MD, MBA – AJMC
Dr Deepak Bhatt
Ravi Vij, MD, MBA – AJMC
Anasuya Gunturi, MD, PhD, Lowell General Hospital
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.